Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide

Critical Care Medicine

Volumn 24, Issue 1 SUPPL., 1996, Pages 131-136

  Hinder, Frank ^a   Booke, Michael ^a   Traber, Lillian D ^a   Matsumoto, Naoki ^a   Nishida, Kazuya ^a   Rogers, Shawn ^a   Traber, Daniel L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Atrial natriuretic peptide; Critical illness; Endotoxemia; Escherichia coli; Hemodynamics; Kidneys; Nitric oxide; Renal function; Sepsis; Sheep

Indexed keywords

ATRIAL NATRIURETIC FACTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; GLOMERULUS FILTRATION RATE; HEART INDEX; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SHEEP; VASCULAR RESISTANCE;

ANIMALS; ARGININE; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CARDIAC OUTPUT; ENDOTOXINS; FEMALE; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; KIDNEY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; SEPSIS; SHEEP; VASCULAR RESISTANCE;

EID: 0029940933     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199601000-00022     Document Type: Article

References (24)

1. Dal Nogar AR: Septic shock. Am J Med Sci 1991; 302:50-65
2. Gray GA, Schott C, Julou-Schaeffer G, et al: The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 1991; 103:1218-1224
3. Shi Y, Li HQ, Shen CK, et al: Plasma nitric oxide levels in newborn infants with sepsis. J Pediatr 1993; 123:435-438
4. Evans T, Carpenter A, Kinderman H, et al: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41:77-81
5. Meyer J, Lentz CW, Stothert JC, et al: Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 1994; 22:306-312
6. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558
7. Rees DD, Palmer RM, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86:3375-3378
8. Biondi ML, Dousa T, Vanhoutte P, et al: Evidences for the existence of endothelium-derived relaxing factor in the renal medulla. Am J Hypertens 1990; 3:876-878
9. Mayer B, John M, Heinzel B, et al: Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxidoreductase. FEBS Lett 1991; 288:187-191
10. Beasley D, Schwartz JH, Brenner BM: Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991; 87:602-608
11. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142
12. Nicolson AG, Haites NE, McKay NG, et al: Induction of nitric oxide synthase in human mesangial cells. Biochem Biophys Res Commun 1993; 193:1269-1274
13. Lahera V, Navarro J, Biondi ML, et al: Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis. Am J Physiol 1993;264:F344-F347
14. Granger JP, Alberola AM, Salazar FJ, et al: Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dogs. J Cardiovasc Pharmacol 1992; 20(Suppl 12):S160-S162
15. G-nitroarginine, in dogs. Am J Hypertens 1992; 5:484-487
16. Lew RA, Baertschi AJ: Endothelium-dependent ANF secretion in vitro. Am J Physiol 1992;263:H1071-H1077
17. Morel DR, Lacroix JS, Hemsen A, et al: Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur J Pharmacol 1989; 167:427-428
18. Mitaka C, Nagura T, Sakanishi N, et al: Plasma alpha-atrial natriuretic peptide concentrations in acute respiratory failure associated with sepsis: Preliminary study. Crit Care Med 1990; 18:1201-1203
19. Lübbesmeyer HJ, Woodson L, Traber LD, et al: Immunoreactive atrial natriuretic factor is increased in ovine model of endotoxemia. Am J Physiol 1988; 254:R567-R571
20. Tresham JJ, Dusting GJ, Coghlan JP, et al: Haemodynamic and hormonal effects of N-nitro-L-arginine, an inhibitor of nitric oxide biosynthesis, in sheep. Clin Exp Pharmacol Physiol 1991; 18:327-330
21. Noshima S, Noda H, Herndon DN, et al: Left ventricular performance during continuous endotoxin-induced hyperdynamic endotoxemia in sheep. J Appl Physiol 1993; 74:1528-1533
22. Meyer J, Hinder F, Stothert J, et al: Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J Appl Physiol 1994;76:2785-2793
23. Hoffend J, Cavarape A, Endlich K, et al: Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation. Am J Physiol 1993; 265:F285-F292
24. Shultz PJ, Tayeh MA, Marietta MA, et al: Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am J Physiol 1991;261:F600-F606